abstract |
The present invention relates to a pharmaceutical composition in the form of a solid dosage, which is particularly suitable for the topical treatment of inflammatory diseases of the oropharynx, wherein the pharmaceutical composition in combination and in each case in pharmaceutically effective amounts (a) at least one mucilaginous drug and / or their extract and (b) polidocanol as a local anesthetic. |